Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Colan Totte CoTSE:7792 +0.34%90 EBITDA Margin % is 29.41% as of Mar. 2026, which is 44% above its 10-year median of 20.43. GuruFocus rates TSE:7792 with a GF Score™ of 90/100 and a GF Value™ of 円1,539.80 (Fairly Valued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Colan Totte Co ranks better than 84.82% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Colan Totte Co's EBITDA for the
three
months ended in Mar. 2026 was 円536 Mil. Colan Totte Co's Revenue for the
three
months ended in Mar. 2026 was 円1,823 Mil. Therefore, Colan Totte Co's EBITDA margin for the quarter that ended in Mar. 2026 was 29.41%.
Colan Totte Co (TSE:7792) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Colan Totte Co EBITDA Margin % Related Terms
Colan Totte Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Colan Totte Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7792 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Colan Totte Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Colan Totte Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Colan Totte Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Colan Totte Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Colan Totte Co (TSE:7792) has a EBITDA Margin % of 29.41% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Colan Totte Co and its competitors. This is 44% above median its historical median of 20.43. Over the past decade, Colan Totte Co's EBITDA Margin % has ranged from 17.49 to 27.20. According to the industry distribution chart, Colan Totte Co ranks #124 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 15.2%.
Is Colan Totte Co's EBITDA Margin % too high?
Colan Totte Co's current EBITDA Margin % of 29.41% is 44% above median its 10-year median of 20.43. Over the past 10 years, this metric has ranged from a low of 17.49 to a high of 27.20. The Medical Devices & Instruments industry median EBITDA Margin % is 7.44. Colan Totte Co's value of 29.41% is 295.3% above this industry median. Based on the distribution chart, Colan Totte Co ranks #124 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Colan Totte Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Colan Totte Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Colan Totte Co ranks #124 out of 817 companies for EBITDA Margin %. This places Colan Totte Co in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.44. Colan Totte Co's value of 29.41% is 295.3% above this benchmark. Historically, Colan Totte Co's own EBITDA Margin % has ranged from 17.49 to 27.20 over the past decade. While the company's 10-year median is 20.43 vs. the industry median of 7.44, Colan Totte Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Colan Totte Co's current EBITDA Margin % of 29.41% is 295.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Colan Totte Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Colan Totte Co's current EBITDA Margin % is 29.41%, which is 44% above median its own 10-year median of 20.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Colan Totte Co stock overvalued right now?
Based on GuruFocus' analysis, Colan Totte Co (TSE:7792) is currently considered Fairly Valued. The stock's GF Value™ is 円1,539.80, compared to a current price of 円1,460.00 — trading 5.2% below its estimated fair value. The current EBITDA Margin % is 29.41%, which is 44% above median its 10-year median of 20.43 and 295.3% above the Medical Devices & Instruments industry median of 7.44. Colan Totte Co's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Colan Totte Co (TSE:7792), the current EBITDA Margin % is 29.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Colan Totte Co (TSE:7792) Overvalued in 2026?
Based on GuruFocus' analysis, Colan Totte Co stock appears to be undervalued.
The current stock price of 円1,460.00 is trading 5.2% below its estimated GF Value™ of 円1,539.80.
GuruFocus considers Colan Totte Co to be Fairly Valued.
Key valuation signals for TSE:7792:
EBITDA Margin %: 29.41% (44% above median its 10-year median of 20.43)
GF Value™: 円1,539.80 vs. price of 円1,460.00 (5.2% below fair value)
Industry Position: 295.3% above the Medical Devices & Instruments median (#124 of 817)
No single metric tells the full story. See the TSE:7792 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Colan Totte Co Ltd is engaged in the manufacturing and sales of medical devices and health products. It divides its business into two segments: Colantotte Business is the brand that develops home magnetic therapy devices, which are the core of the company; and CSS Business is a service that connects people with their families, realizing contacting designated emergency contacts based on the desire to protect loved ones.
90GF Score
Get the complete analysis for TSE:7792
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7792 has been successfully added to your 
